Safety and Effect of Oral RVX000222 in Subjects With Fabry Disease
Clinical trial NCT03228940 · WITHDRAWN
Trial details
- NCT number
- NCT03228940
- Sponsor
- Resverlogix Corp
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-22
- Primary completion
- 2022-11-22
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.